Therefore, loss of ZBTB7A may facilitate the onset of t (8;21) AML, and that RUNX1-RUNX1T1-rearranged leukemia might be mimicked by glycolytic inhibitors because lack of ZBTB7A can enhance glycolysis [15]. Here, RUNX1T1 is linked to acute myeloid leukemia.